Product Information
DOFETILIDE 125 MCG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.2026 per EA under NDC 76282075560. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Oct 14, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282075560
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212750FDA Approved
10/14/2021
TE Code
AB
On Market Since
11/1/2024
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 125 MCG CAPSULE has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2026 per EA |
|---|---|
| All-time high | $0.2425 (Apr 16, 2025) |
| All-time low | $0.1925 (Feb 18, 2026) |
| 52-week high | $0.2198 |
| 52-week low | $0.1925 |
| Median price | $0.2046 |
| Average price | $0.2080 |
| Largest weekly change | -8.6% (May 21, 2025) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dofetilide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOFETILIDE 125 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 125 MCG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.2026 per EA (NDC 76282075560), effective Sep 30, 2026.
How has the price of DOFETILIDE 125 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 125 MCG CAPSULE has declined 16.5%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 125 MCG CAPSULE?
Since Apr 9, 2025, the NADAC for DOFETILIDE 125 MCG CAPSULE has ranged from a low of $0.1925 (Feb 18, 2026) to a high of $0.2425 (Apr 16, 2025), with a median of $0.2046 per EA.
Are there cheaper alternatives to DOFETILIDE 125 MCG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOFETILIDE 125 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOFETILIDE 125 MCG CAPSULE?
DOFETILIDE 125 MCG CAPSULE (NDC 76282075560) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.